A Randomized, Double Blind, Double Dummy, Placebo Controlled Phase III Trial to Evaluate the Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia(COCTAIL Study)
Phase of Trial: Phase III
Latest Information Update: 27 Jun 2014
At a glance
- Drugs Pitavastatin (Primary) ; Valsartan (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
- Acronyms COCTAIL
- Sponsors JW Pharmaceutical
- 10 Jun 2017 Biomarkers information updated
- 27 Jun 2014 Last checked against ClinicalTrials.gov record.
- 12 May 2014 Trial status changed to completed as reported by ClinicalTrials.gov.